Sarita Shah, MD, MPH, is Professor at Emory University in the Rollins School of Public Health (Global Health and Epidemiology) and School of Medicine (Infectious Diseases). Her research and public health work have focused on drug-resistant TB and TB/HIV co-infection for the past two decades in several high-burden settings throughout sub-Saharan Africa and Asia. She received her undergraduate and medical degrees from Johns Hopkins University, followed by clinical training in Internal Medicine and a Master of Public Health (MPH) degree at Columbia University's New York-Presbyterian Hospital and Mailman School of Public Health, respectively. Dr. Shah then served as an Epidemic Intelligence Service (EIS) Officer at the U.S. Centers for Disease Control and Prevention (CDC) in the Division of TB Elimination, where she conducted seminal studies on drug-resistant TB and TB/HIV. Prior to joining the faculty at Emory University in March 2020, Dr. Shah was a Team Lead and Associate Chief of Science in the Global TB Branch at CDC, where she and her team were involved with supporting TB and HIV services in PEPFAR (President’s Emergency Plan for AIDS Relief) programs in over 15 countries. She serves on the NIH AIDS Clinical Trials Group (ACTG) TB Transformative Science Group, the Global Fund Technical Review Panel, and was the TB subject group lead for the NIH-CDC-HIVMA/IDSA Opportunistic Infections guidelines for HIV-infected adults and adolescents. Dr. Shah is also a clinical care provider for people with HIV at the Atlanta Veterans Affairs Medical Center and is a mentor for several students, fellows, and public health professionals in the U.S. and internationally. Her research and public health work have been covered by the New York Times, National Public Radio, CNN, Wall Street Journal, Washington Post, and others.